Prof. Koushik LahiriMBBS, DVD(CAL), IFAAD, FRCP (Edin), FRCP (London)(United Kingdom)
Dr. Koushik Lahiri is a highly accomplished dermatologist and academician with a wide range of achievements and contributions to the field. He has authored six books, including 29 chapters and 110 articles, reflecting his extensive research interests. Dr. Lahiri has been recognized with 1549 citations and over 60,000 reads, highlighting the impact of his work. His RG Score stands at 32.68, while his h-index is 18, and i-10 index is 33. Additionally, he has received prestigious awards and orations, both nationally and internationally, for his significant contributions to dermatology. Dr. Lahiri is involved in various professional organizations, holding leadership positions, and has played a key role in conceptualizing and establishing important initiatives in the field.
Vitiligo Minigrafting: an Experience of 3 Decades
Presentation on Vitiligo minigrafting by Professor Koushik Lahiri at shariing his decades of experience and knowledge on the topic. He then goes on to describe the vitiligo mini punch grafting technique, including the necessary instruments and the steps involved in the procedure, with very practical examples as well as an extensive coverage of the side effects. The presentation also includes a video of a vitiligo surgery and the post-operative dressing. Dr. Lahiri emphasizes the importance of follow-up visits and the use of narrowband UVB to achieve complete repigmentation
In this presentation, Professor Rashmi Sarkar talks about melasma, a common hyperpigmentary disorder that affects sun-exposed areas, mostly the face, and occurs more commonly in females. The causes of melasma include genetic influences, sunlight (UVA, UVB, visible light, and infrared radiation), hormonal contraceptives, pregnancy, cosmetics, endocrine factors (especially thyroid dysfunction), and medications. Melasma’s pathogenesis is a complex process that involves epidermal hyper-melanosis, melanocytes, genetic factors, racial factors, hormonal factors, sun exposure, oxidants, antioxidants, and vascular factors. The treatment of melasma is challenging, and the therapeutic options include topical sunscreens, topical hypopigmentation agents, chemical peels, lasers, physical modalities, oral agents, and cosmetic camouflage. Newer demelanizing agents include Soybean trypsin inhibitor, Licorice, Niacinamide, Flavonoids, Silymarin, Oligopeptides, tropical Metformin, Tranexamic acid, Polypodium leucotomos, Proanthocyanidins, and Pycnogenol. Tranexamic acid has stood the test of time as a systemic agent for the treatment of melasma.
To Study the Efficacy of Cultured Versus Non-Cultured Melanocyte Transfer in the Surgical Management of Stable Vitiligo: A Randomized Controlled Trial
Prof. AL-NIAIMI Firas
Professor Firas Al-Niaimi is a highly experienced and skilled consultant dermatologist, Mohs and laser expert with nearly 20 years’ experience and an international standing trained in some of the UK's top hospitals and fellowship-trained in dermatologic surgery and lasers at St. Thomas’ hospital in London where he continued to work there as an honorary consultant for a number of years before moving to fulltime private practice. His passion for education, research and science has led him to publish over 210 publications in Dermatology and lasers including his own published book and 10 book chapters making him one of the most prolific and well-published consultant dermatologists in the UK. In addition to this he has delivered more than 400 scientific presentations in 55 countries around...
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.